25th Oct 2010 17:30
SPH.L Sinclair Pharma plc Posting of 2010 Annual Report and Notice of AGM
25 October 2010, Godalming, UK: Sinclair Pharma plc (SPH:L), the international specialty pharma company, announces that it has posted to shareholders its Annual Report and Accounts for the year ended 30 June 2010, together with notice of its annual general meeting ("AGM"), which is to be held at the offices of Fasken Martineau LLP, 17 Hanover Square, London, W1S 1HU on 18th November 2010 at 10.00 a.m.
Copies of the Annual Report and Accounts and Notice of AGM are available on the company's investor relations website at www.sinclairpharma.com. Copies of the Annual Report and Notice of AGM have been submitted to the National Storage Mechanism and will shortly be available for viewing at www.hemscott.com/nsm.do.
For further information please contact:
Sinclair Pharma plc Tel: +44 (0)1483 410 600Christopher Spooner, CEOAlan Olby, CFOSinger Capital Markets Ltd Tel: +44 (0)20 3205 7500Shaun DobsonClaes Sp¥ng
Biddicks, Financial Public Relations Tel +44 (0)20 7448 1000
Shane Dolan
About Sinclair Pharma Plc www.sinclairpharma.com
Sinclair Pharma plc is an international specialty pharmaceutical company providing solutions to treat wounds, dermatological and oral diseases through advanced surface technology and innovative delivery systems. It has a growing sales and marketing operation that is present in France, Italy, Germany and Spain, and an extensive marketing partner network across selected developed & emerging markets.
"Safe Harbor" Statement under the US Private Securities Litigation Reform Act of 1995: Some or all of the statements in this document that relate to future plans, expectations, events, performances and the like are forward-looking statements, as defined in the US Private Securities Litigation Reform Act of 1995. Actual results of events could differ materially from those described in the forward-looking statements due to a variety of factors.
vendorRelated Shares:
Sinclair Pharma